Precision VIR Announces Non-surgical Option for Patients with Varicose Veins

Vein expert doctors at Precision VIR in Dallas, TX announce Varithena as a non-surgical option for varicose vein patients. Sadly, vein disease does not cure itself and can get worse if untreated. Precision VIR can reduce varicose vein symptoms and improve leg appearance.

Dallas, United States - April 17, 2018 /PressCable/ —

Precision VIR Announces Availability of Varithena® as a Non-Surgical Option for Patients with Symptoms Related to or Caused by Varicose Veins

The Cutting-Edge Procedure can Reduce a Variety of Symptoms and Improve Vein Appearance

Dallas, TX (April 16, 2018) – The doctors at Precision Vascular & Interventional recently announced they incorporated Varithena® (polidocanol injectable foam) into the growing list of superior vein treatment options for their patients. Varithena is a non-surgical prescription medicine many believe can be a game-changer when it comes to treating varicose veins, specifically in combating the symptoms of heaviness, achiness, swelling, throbbing and itching.

“Precision VIR is delighted to provide patients with this non-surgical option,” Dr. Danny Chan said on behalf of himself, Dr. Jaryd Stein, and their associate vein specialists. “We have been specially trained in using Varithena. Treatment is minimally-invasive—which means no incision is required.”

Dr. Chan added, “The Varithena procedure usually takes less than one hour, and patients may resume light activities as quickly as the same day of treatment.”

More About Varicose Veins and Varithena

Varicose veins are enlarged bulging veins usually found above the surface of the skin on the legs and are a telltale sign of vein disease, where vein walls and valves have become weakened and eventually interrupt normal blood flow. These veins can range from the most common spider and varicose veins to skin breakdown and venous ulcers. More than 20 million Americans suffer from vein disease or venous disorders.

Sadly, vein disease does not cure itself and can get worse if left untreated. Luckily, there are a variety of treatment options available for patients with venous conditions, including Varithena, Sclerotherapy, ClosureFast, and Microphlebectomy.

Varithena (polidocanol injectable foam) is the latest option. It is administered through a catheter or by direct injection into the malfunctioning vein. The foam fills the desired section of the vein, and the diseased vein collapses. Blood flow then shifts to healthier veins nearby. This procedure does not require incisions. While the doctor usually numbs the injection site, no additional anesthesia is required.

Varithena treats a wide range of varicose veins in the GSV system, including:

• Tortuous (twisted) veins

• Veins above and below the knee

• Veins with small, medium, and large diameters

• Veins previously treated with other methods

Varithena® is a registered trademark of Provensis Ltd, a BTG International group company.

Precision VIR – Committed to Helping Patients Lead Normal Lives

Precision VIR has long been at the forefront of performing leading-edge procedures to treat vein disease such as varicose veins, spider veins, deep vein thrombosis (DVT), chronic venous insufficiency (CVI), and peripheral arterial disease/peripheral vascular disease (PAD/PVD)—all while providing compassionate patient care.

With multiple locations in the Dallas-Fort Worth area, Precision VIR was established in 2012 as the first independent Vascular and Interventional Radiology practice in North Texas. They focus only on minimally-invasive procedures and surgeries that are the safest and most efficient options for patients. There are no large incisions, which allows for a reduction in risk, less pain, and shorter recovery time.

All physicians at Precision VIR are Board Certified Diagnostic Radiologists with additional Fellowship training in Vascular and Interventional Radiology. Precision VIR serves Dallas, Fort Worth, Carrollton, Richardson, Garland, Mesquite, Highland Park, University Park, Park Cities, Plano, Frisco, Allen, McKinney, Flower Mound, Lewisville, Denton, Arlington, Irving, Grand Prairie and all of North Texas. Precision VIR doctors are area leaders in vascular disease diagnosis and treatment for conditions such as varicose veins, spider veins, deep vein thrombosis (DVT), chronic venous insufficiency (CVI), peripheral arterial disease/peripheral vascular disease (PAD/PVD), IVC filters, women’s pelvic congestion syndrome, male varicoceles and female uterine fibroids.

For more information on Varithena, visit the Precision VIR FAQ page or to see if this procedure is the right treatment for your varicose veins, schedule a consultation by calling (214) 382-3200.

– end –

###

Contact Info:
Name: Shauna Robinson or Madison Horan
Email: info@precisionvir.com
Organization: Precision VIR
Address: 12400 Coit Road, Suite 505, Dallas, TX 75251, United States
Phone: +1-214-382-3200

For more information, please visit https://www.precisionvir.com/vein-care-dallas/

Source: PressCable

Release ID: 331770

More News From Banking Reporter

Stocks drop after Trump says he's ready to step up trade war

Jul 20, 2018

SINGAPORE — World stock markets fell sharply Friday after U.S. President Donald Trump said he was prepared to put new tariffs on all Chinese imports, escalating the rhetoric in a trade war that could hit global economic growth. KEEPING SCORE: From being up slightly earlier in the day, European indexes were trading lower. Germany's DAX fell 0.5 percent to 12,622 while France's CAC 40 dropped 0.7 percent at 5,377. Britain's FTSE 100 fell 0.3 percent to 7,661. U.S. indexes were poised to open lower, with S&P 500 futures down 0.2 percent and Dow futures 0.4 percent lower. TRUMP TALK: Trump...

Asian markets fall as China, US ready for more tariffs

Jul 20, 2018

SINGAPORE — Asian markets wobbled Friday on signs that China and the U.S. were preparing to impose more tariffs on each other's products. KEEPING SCORE: Japan's Nikkei 225 lost 0.5 percent to 22,652.42 and South Korea's Kospi dropped less than 0.1 percent to 2,281.69. Hong Kong's Hang Seng slipped 0.6 percent to 27,858.02. The Shanghai Composite Index edged 0.1 percent lower to 2,769.06. Australia's S&P-ASX 200 bucked the regional trend, adding 0.4 percent to 6,286.00. WALL STREET: U.S. indexes finished mostly lower. The S&P 500 index lost 0.4 percent to 2,804.49 on Thursday. The Dow Jones Industrial Average gave up...

Global stocks drift lower as US considers more tariffs

Jul 20, 2018

SEOUL, South Korea — Global stock markets drifted lower Thursday as the U.S. mulled whether to impose new tariffs on autos and auto parts. Europe said it was preparing to retaliate in kind, denting one of the key drivers of global growth. KEEPING SCORE: Germany's DAX fell 0.4 percent to 12,713 and France's CAC 40 was down 0.5 percent at 5,420. Britain's FTSE 100 was flat at 7,678. Futures augured small losses on Wall Street, with S&P and Dow futures both down 0.2 percent. AUTO TARIFFS: The next big event on the global trade front may be the U.S. Commerce...

Investor frenzy in S. Korea over Russia treasure ship rumors

Jul 20, 2018

SEOUL, South Korea — A South Korean company's claim to have found a sunken Russian warship has triggered investor frenzy amid speculation the ship was carrying an enormous amount of gold when it sank 113 years ago. South Korea's financial regulator subsequently issued a warning against possible investment losses. The Seoul-based Shinil Group said Tuesday its divers discovered what a wreck it identified as the 6,200-ton Dmitrii Donskoi, which went down during the 1904-1905 Russo-Japanese war off an eastern Korean island. The company speculated about 200 tons of gold bars and coins that are worth 150 trillion won ($132 billion)...

Asian stocks drift as investors await fresh moves on trade

Jul 20, 2018

SEOUL, South Korea — Asian stock markets were drifting Thursday in mixed trading as investors awaited further moves in global trade disputes. KEEPING SCORE: Japan's Nikkei 225 added 0.2 percent to 22,839.59, while South Korea's Kospi shed 0.2 percent to 2,285.99. Hong Kong's Hang Seng edged 0.1 percent lower to 28,107.16 while the Shanghai Composite Index slipped 0.3 percent to 2,777.41. Australia's S&P-ASX 200 gained 0.3 percent to 6,265.00. ASIAN DEVELOPMENT BANK OUTLOOK: The Manila, Philippines-based Asian Development Bank issued a revised economic forecast for the region and for major industrial economies that kept mostly unchanged the estimates for growth...

About Us

Banking Reporter is the largest-circulated online business news in the United States, bringing a whole new genre of business journalism more up close and more incisive.

Contact us: sales[at]bankingreporter.com

Subscribe Now!